Price $0.23 |
Market Cap
4.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.19
|
P/S
0.35
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-4.5K
|
FCF
-
|
|
Op. Margin
-86.10%
|
Net Margin
-91.10%
|
ROE
-45.20%
|
ROI
-28.40%
|
|
ROA
-38.30%
|
EPS Growth
45.60%
|
Current Ratio
11.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Evofem Biosciences Inc (EVFM) | $0.05 | - | - | 6.3M | Strong Buy |
| Clover Health Investments Corp (CLOV) | $1.20 | - | - | 443.2M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.21 | - | - | 54.1M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $0.56 | - | - | 1.9M | Strong Buy |
| China Pharma Holdings Inc (CPHI) | $0.10 | - | - | 5.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
